Speaking at the Fortune Global Forum yesterday, embattled Theranos CEO Elizabeth Holmes defended her company’s blood test technology, while promising to become more transparent in the future.
Elizabeth Holmes, the beleaguered founder-and-chief of Theranos, has agreed to publish scientific data that will supposedly affirm the accuracy and reliability of its blood tests. But as a recent FDA inspection report points out, things don’t look good.
Theranos seemed to be offering a miraculous new service: a single finger pinprick could yield the results of up to 200 different blood tests. But a scathing report in the The Wall Street Journal punctured these claims. Now Theranos CEO Elizabeth Holmes has come to her company’s defense.
Nobody really likes getting blood drawn. Best case, it’s painless and you’re out of the doctor’s office quickly. But then there are those instances where you end up killing an afternoon at the clinic, only to have an intern stab your arm in five different places before hitting a vein.
As part of Walgreens' recent initiative to be a "leader in healthcare technology," the company is teaming up with Silicon Valley health startup Theranos to offer cheap, needle-free blood tests. What's more, the service will soon be coming to a drugstore near you, as they're planning to expand it to all 8,200 locations.
Early detection is the best tool to fight cancer, but biopsies can be painful and inconclusive. New research shows a simple blood test can detect cancers by blasting white blood cells with UV and seeing how they respond. Painless, universal cancer detection could be a drop of blood away.
A new test set to hit the market in Britain in the next year aims to tell patients how long they have to live, and naturally that's not happening without controversy. The test measures a person's telomeres, those structures found on the tips of chromosomes. The length of telomeres apparently correlates with how fast a…